Metaculus Help: Spread the word
If you like Metaculus, tell your friends! Share this question via Facebook, Twitter, or Reddit.
By 2020, will an implanted human embryo with artificially edited DNA be brought to term?
In April of 2015, it was announced that scientists in China had successfully edited the genome of a human embryo using the CRISPR/Cas9 system--a standard synthetic biology tool for gene editing. February 1st of this 2016 marked another major turning point in the field when UK regulators approved gene editing in viable human embryos. This is the first time that any kind of regulatory agency has approved the use of synthetic techniques in humans at the embryonic stage. This may present an open door for other agencies to make similar judgments. It should be noted that the genes targeted in the newly-approved study were chosen by the UK researchers to probe embryonic development, and specifically disapproved for future implantation and maturation.
Single-cell embryos are excellent subjects for CRISPR research; their relatively large size enables routine microinjection of the biological macromolecules necessary to perform the edit. A significant drawback, however, is CRISPR efficiency. Like any mutagenic process, it leaves a lot of room for improvement. Its targets still have a low chance of being successfully and appropriately edited, thus requiring a sequencing screen to find a match. This has the potential to leave many human embryos unwanted or no longer viable, as in the relatively rare case of an improper edit.
On the other hand, there are a number of genetic disorders (cystic fibrosis, for instance) that are rapidly fatal anyway, presenting some cases as prime candidates for CRISPR editing. Now, development of the system in human embryos has precedent, which may lead to other agencies following the example set by the UK. While still strictly illegal in the UK and US,
by 2020, will the remaining roadblocks be lifted (or circumvented), leading to an implanted human embryo brought fully to term with CRISPR (or a similar system) edited DNA?
This question will resolve positively if the aforementioned event is reported in one of the top 25 media outlets by October 1st, 2020.
Metaculus help: Predicting
Predictions are the heart of Metaculus. Predicting is how you contribute to the wisdom of the crowd, and how you earn points and build up your personal Metaculus track record.
The basics of predicting are very simple: move the slider to best match the likelihood of the outcome, and click predict. You can predict as often as you want, and you're encouraged to change your mind when new information becomes available. With tachyons you'll even be able to go back in time and backdate your prediction to maximize your points.
The displayed score is split into current points and total points. Current points show how much your prediction is worth now, whereas total points show the combined worth of all of your predictions over the lifetime of the question. The scoring details are available on the FAQ.
Note: this question resolved before its original close time. All of your predictions came after the resolution, so you did not gain (or lose) any points for it.
Note: this question resolved before its original close time. You earned points up until the question resolution, but not afterwards.
This question is not yet open for predictions.
Metaculus help: Community Stats
Use the community stats to get a better sense of the community consensus (or lack thereof) for this question. Sometimes people have wildly different ideas about the likely outcomes, and sometimes people are in close agreement. There are even times when the community seems very certain of uncertainty, like when everyone agrees that event is only 50% likely to happen.
When you make a prediction, check the community stats to see where you land. If your prediction is an outlier, might there be something you're overlooking that others have seen? Or do you have special insight that others are lacking? Either way, it might be a good idea to join the discussion in the comments.